Lindbrook Capital’s Protolabs PRLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-24
Closed -$705 2880
2024
Q3
$705 Sell
24
-192
-89% -$5.86K ﹤0.01% 2581
2024
Q2
$6.67K Hold
216
﹤0.01% 1858
2024
Q1
$7.72K Hold
216
﹤0.01% 1694
2023
Q4
$8.41K Sell
216
-297
-58% -$9.62K ﹤0.01% 1638
2023
Q3
$13.5K Buy
513
+23
+5% +$694 ﹤0.01% 1257
2023
Q2
$17.1K Hold
490
﹤0.01% 1173
2023
Q1
$16.2K Sell
490
-8
-2% -$247 ﹤0.01% 1178
2022
Q4
$12.7K Buy
498
+484
+3,457% +$14.4K ﹤0.01% 1309
2022
Q3
$1K Sell
14
-24
-63% -$1.04K ﹤0.01% 2459
2022
Q2
$2K Buy
38
+6
+19% +$278 ﹤0.01% 2033
2022
Q1
$2K Buy
32
+15
+88% +$789 ﹤0.01% 2056
2021
Q4
$1K Sell
17
-10
-37% -$590 ﹤0.01% 1975
2021
Q3
$2K Buy
+27
New +$2.11K ﹤0.01% 1590
2021
Q1
Sell
-25
Closed -$4K 1926
2020
Q4
$4K Buy
+25
New +$3.53K ﹤0.01% 1271

Other funds holding PRLB

Lindbrook Capital's PRLB Position: Q4 2024 in Review

Lindbrook Capital sold out of Protolabs (PRLB) in Q4 2024, closing a stake of 24 shares — an estimated $705 sold.

Lindbrook Capital first reported a position in PRLB in Q4 2020 and held it in 14 quarters. The position peaked at $17.1K in Q2 2023. 199 funds tracked by Wall St. Rank hold PRLB as of Q4 2024.

  • Lindbrook Capital reported no remaining Protolabs position as of Q4 2024 after selling out during the quarter.
  • Lindbrook Capital sold 24 Protolabs shares in Q4 2024, an estimated $705.
  • Lindbrook Capital first reported a position in Protolabs in Q4 2020 and held it in 14 quarters.
  • Lindbrook Capital's Protolabs position peaked at $17.1K in Q2 2023.
  • 199 funds tracked by Wall St. Rank held Protolabs as of Q4 2024.

Based on Lindbrook Capital's 13F filing for Q4 2024, filed 6 Feb 2025.